These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8618702)

  • 1. Development of general weakness in a patient with amyotrophic lateral sclerosis after focal botulinum toxin injection.
    Mezaki T; Kaji R; Kohara N; Kimura J
    Neurology; 1996 Mar; 46(3):845-6. PubMed ID: 8618702
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin: risk of death. Beware muscle symptoms.
    Prescrire Int; 2008 Jun; 17(95):112. PubMed ID: 18630354
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases.
    Bhatia KP; Münchau A; Thompson PD; Houser M; Chauhan VS; Hutchinson M; Shapira AH; Marsden CD
    J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):90-3. PubMed ID: 10369829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Tan EK; Lo YL; Seah A; Auchus AP
    J Neurol Sci; 2001 Sep; 190(1-2):95-7. PubMed ID: 11574113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The symptomatic treatment of amyotrophic lateral sclerosis].
    van den Berg LH; van den Berg JP; Mathus-Vliegen EM; Kampelmacher MJ; van Kesteren RG; Jennekens FG
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):513-8. PubMed ID: 15054949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for painful limbs moving extremities: are distal injections critical?
    Alvarez MV; Evidente VG; Grogan PM
    Parkinsonism Relat Disord; 2010 Dec; 16(10):693-4. PubMed ID: 20800531
    [No Abstract]   [Full Text] [Related]  

  • 8. Pearls and pitfalls in the therapeutic use of botulinum toxin.
    Smith AG
    Semin Neurol; 2004 Jun; 24(2):165-74. PubMed ID: 15257513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expiratory muscle weakness and assisted cough in ALS.
    Lahrmann H; Wild M; Zdrahal F; Grisold W
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):49-51. PubMed ID: 12745619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of botulinum toxin injection in treatment of achalasia].
    Hoeft SF; Porschen R
    Z Gastroenterol; 2000 Jan; 38(1):133-5. PubMed ID: 10689751
    [No Abstract]   [Full Text] [Related]  

  • 12. Pain and remote weakness in limbs injected with botulinum toxin A for writer's cramp.
    Sheean GL; Murray NM; Marsden CD
    Lancet; 1995 Jul; 346(8968):154-6. PubMed ID: 7603232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of both tardive dystonia and akathisia after botulinum toxin injection.
    Shulman LM; Singer C; Weiner WJ
    Neurology; 1996 Mar; 46(3):844-5. PubMed ID: 8618701
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.
    Crowner BE; Torres-Russotto D; Carter AR; Racette BA
    Clin Neuropharmacol; 2010; 33(5):243-7. PubMed ID: 20852412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of botulinum toxin injections in the management of muscle overactivity of the lower limb.
    Gracies JM; Singer BJ; Dunne JW
    Disabil Rehabil; 2007 Dec; 29(23):1789-805. PubMed ID: 18033604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uses of botulinum toxin.
    Schnider P; Binder M; Kittler H; Steinhoff N; Auff E
    Lancet; 1997 Mar; 349(9056):953. PubMed ID: 9093270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.